Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastroesophageal Adenocarcinoma

NCT03395847 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03395847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03395847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastroesophageal Adenocarcinoma
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
February 9, 2018
Completion date
January 27, 2023
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastroesophageal junction adenocarcinoma, clinical stage iii esophageal adenocarcinoma ajcc v8, clinical stage iii gastric cancer ajcc v8, clinical stage iv esophageal adenocarcinoma ajcc v8, clinical stage iv gastric cancer ajcc v8, clinical stage iva esophageal adenocarcinoma ajcc v8, clinical stage iva gastric cancer ajcc v8, clinical stage ivb esophageal adenocarcinoma ajcc v8, clinical stage ivb gastric cancer ajcc v8, gastroesophageal junction adenocarcinoma, metastatic gastroesophageal junction adenocarcinoma, pathologic stage iii esophageal adenocarcinoma ajcc v8, pathologic stage iii gastric cancer ajcc v8, pathologic stage iiia esophageal adenocarcinoma ajcc v8, pathologic stage iiia gastric cancer ajcc v8, pathologic stage iiib esophageal adenocarcinoma ajcc v8, pathologic stage iiib gastric cancer ajcc v8, pathologic stage iiic gastric cancer ajcc v8, pathologic stage iv esophageal adenocarcinoma ajcc v8, pathologic stage iv gastric cancer ajcc v8, pathologic stage iva esophageal adenocarcinoma ajcc v8, pathologic stage ivb esophageal adenocarcinoma ajcc v8, postneoadjuvant therapy stage iii gastric cancer ajcc v8, postneoadjuvant therapy stage iv gastric cancer ajcc v8, unresectable gastroesophageal junction adenocarcinoma